Eurocine Vaccines Balance Sheet Health
Financial Health criteria checks 1/6
Eurocine Vaccines has a total shareholder equity of SEK-232.0K and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK1.8M and SEK2.0M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr1.31m |
| Equity | -kr232.00k |
| Total liabilities | kr1.99m |
| Total assets | kr1.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EUCI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: EUCI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: EUCI is debt free.
Reducing Debt: EUCI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EUCI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EUCI has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.9% each year.